Therapy

Cyramza Receives Fast-Track Approval for Advanced Stomach Cancer

INDIANAPOLIS – A new therapy has received fast-track approval for treatment of advanced stomach cancer. The Food and Drug Administration has approved Cyramza (ramucirumab) to treat patients with gastroesophageal junction adenocarcinoma. Cyramza, marketed by Eli Lilly of Indianapolis, is an… Read More